Africa: Investing in New TB Vaccines - It's Time to End the Century-Long Wait!

press release

Dear colleagues, partners and friends,

A century has passed since the Bacillus Calmette-Guérin (BCG) vaccine was introduced to combat tuberculosis (TB) on 18 July, 1921. The BCG vaccine is currently the only licensed vaccine for TB and provides moderate protection against severe forms of TB in infants and young children. It has been made widely available across countries through immunization programmes and has played a vital role in saving many young lives and preventing serious illnesses. However, there is no vaccine that is effective in preventing TB disease in adults, either before or after exposure to TB infection. While results from a Phase II trial of the M72/AS01E TB vaccine candidate are promising - from among 14 vaccine candidates in clinical trials, these vaccines are expected to be ready only in the coming years.

...

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.